Bioscience Division,
High Content Analysis Research and Development,
Bioscience Division, High Content Analysis Research and Development
Janet L Anderl has not added Biography.
If you are Janet L Anderl and would like to personalize this page please email our Author Liaison for assistance.
Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events.
Clinical cancer research : an official journal of the American Association for Cancer Research May, 2011 | Pubmed ID: 21364033
Millipore Inc
Janet L Anderl1,
Stella Redpath1,
Andrew J Ball1
1Bioscience Division, High Content Analysis Research and Development, Millipore Inc
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
Recherche
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
Enseignement
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. Tous droits réservés.